Corcept Therapeutics CORT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's short-term investments?
- Corcept Therapeutics (CORT) reported short-term investments of $229.45M in Q1 2026.
- How has Corcept Therapeutics's short-term investments changed year-over-year?
- Corcept Therapeutics's short-term investments decreased by 1.5% year-over-year, from $232.94M to $229.45M.
- What is the long-term trend for Corcept Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Corcept Therapeutics's short-term investments has grown at a -7.1% compound annual growth rate (CAGR), from $364.51M to $251.66M.
- What does short-term investments mean?
- Liquid assets or securities that can be converted to cash within a year.
- How do you interpret short-term investments?
- High levels indicate strong liquidity and a conservative cash management strategy, while low levels may suggest cash is being deployed for growth.
- How does short-term investments compare across companies?
- High for cash-rich pharmaceutical companies; low for capital-intensive or distressed firms.